How Will the Market React to Syros Pharmaceuticals Inc (SYRS) Stock Getting a Bullish Rating

Syros Pharmaceuticals Inc (SYRS) stock has gained 24.72% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Syros Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SYRS!

See Full SYRS Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SYRS Stock Today?

Syros Pharmaceuticals Inc (SYRS) stock is trading at $6.66 as of 3:33 PM on Tuesday, Oct 4, a gain of $0.72, or 12.12% from the previous closing price of $5.94. The stock has traded between $6.16 and $6.81 so far today. Volume today is less active than usual. So far 165,238 shares have traded compared to average volume of 381,975 shares.

More About Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States. Click Here to get the full Stock Report for Syros Pharmaceuticals Inc stock.